| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000033613 |
| Receipt No. | R000038333 |
| Scientific Title | Randomized controlled trials on prevention of sarcopenia during gastric cancer surgery by exercise and nutrition intervention |
| Date of disclosure of the study information | 2018/08/02 |
| Last modified on | 2020/08/03 (Ver. 5) |
| Basic information | ||
| Public title | Randomized controlled trials on prevention of sarcopenia during gastric cancer surgery by exercise and nutrition intervention | |
| Acronym | Randomized controlled trials on prevention of sarcopenia during gastric cancer surgery by exercise and nutrition intervention | |
| Scientific Title | Randomized controlled trials on prevention of sarcopenia during gastric cancer surgery by exercise and nutrition intervention | |
| Scientific Title:Acronym | Randomized controlled trials on prevention of sarcopenia during gastric cancer surgery by exercise and nutrition intervention | |
| Region |
|
|
| Condition | ||
| Condition | Gastric Cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Verify the prevention effect of sarcopenia during gastric cancer surgery by exercise and nutrition intervention. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Incidence of sarcopenia |
| Key secondary outcomes | Weight, skeletal muscle mass, perioperative complications, hematological nutritional indicators, duration of postoperative chemotherapy, QOL, exercise habits, physical fitness tests, blood hormone, immunity and inflammatory cytokines |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Treatment intervention group
Perioperative resistance training, amino acid intake from 3 weeks or more before surgery to 3 months after surgery |
||
| Interventions/Control_2 | Standard treatment group | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients scheduled to undergo gastric cancer surgery
PS 0-2 Consent has been obtained |
|||
| Key exclusion criteria | Patients take preoperative chemotherapy.
Exercise training is diagnosed as inappropriate by general condition. Patients take warfarin. The doctor in charge judged it to be inappropriate. |
|||
| Target sample size | 150 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | The University of Tokyo | ||||||
| Division name | Department of Bariatric & Metaboric Care | ||||||
| Zip code | 113-8655 | ||||||
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3815-5411 | ||||||
| aikous-tky@umin.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | The University of Tokyo | ||||||
| Division name | Department of Bariatric & Metaboric Care | ||||||
| Zip code | 113-8655 | ||||||
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3815-5411 | ||||||
| Homepage URL | |||||||
| aikous-tky@umin.ac.jp | |||||||
| Sponsor | |
| Institute | The University of Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | RIZAP Inc. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Research Ethics Committee of the Faculty of Medicine of the University of Tokyo |
| Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo |
| Tel | 03-5841-0818 |
| ethics@m.u-tokyo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 24 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038333 |